Arkolith/Insider Trading/ORTX/Form 4

Gaspar Bobby

Chief Executive Officer, DirectorOrchard Therapeutics plc (ORTX) · full profile →Form 4 · filed Jan 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
13
1 non-derivative · 12 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2024Disposed to issuer(D)366K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 24, 2024Disposed to issuer(D)96K—$00
Jan 24, 2024Disposed to issuer(D)40K—$00
Jan 24, 2024Disposed to issuer(D)598K—$00
Jan 24, 2024Disposed to issuer(D)50K—$00
Jan 24, 2024Disposed to issuer(D)582K—$00
Jan 24, 2024Disposed to issuer(D)563K—$00
Jan 24, 2024Disposed to issuer(D)427K—$00
Jan 24, 2024Disposed to issuer(D)423K—$00
Jan 24, 2024Disposed to issuer(D)55K—$00
Jan 24, 2024Disposed to issuer(D)850K—$00
Jan 24, 2024Disposed to issuer(D)300K—$00
Jan 24, 2024Disposed to issuer(D)200K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-007058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML